Publications by authors named "Pascal Benkert"

Claim this Profile
C
Comparative analysis of three platforms for serum NfL quantification in healthy controls and MS patients.
Justina Dargvainiene, Antje Torge, Klaus-Peter Wandinger, Ralf Junker, Robert Markewitz, Pascal Benkert

Clin Chem Lab Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, Johanna Oechtering, Sabine Schaedelin, Pascal Benkert

Ann Clin Transl Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.
Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin, Johanna Oechtering

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning, Pascal Benkert, W John Boscardin

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay.
Ronald A Booth, Daniel Beriault, Raphael Schneider, Pascal Benkert, Eline A J Willemse

Clin Chim Acta· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.
Xinjie Chen, Po-Jui Lu, Mario Ocampo-Pineda, Alessandro Cagol, Sabine Anna Schaedelin, Pascal Benkert

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
Roberto Furlan, Sabine Schaedelin, Jette Lautrup Frederiksen, Mitsuru Watanabe, Fredrik Piehl, Pascal Benkert

Brain· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, Pascal Benkert, Cathrine Axfors

Neurol Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, Amit Bar-Or, Viviane Bohner-Lang

Mult Scler· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome.
Rafael Klimas, Felix Kohle, Lea Horstkemper, Pascal Benkert, Adriana Rehm

Neurol Neuroimmunol Neuroinflamm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, Pascal Benkert, Lester Melie-Garcia

J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD.
Patrick Schindler, Ulrike Grittner, Rebekka Rust, Susanna Asseyer, Judith Bellmann-Strobl, Pascal Benkert

Ther Adv Neurol Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Serkan Ozakbas, Rana Karabudak, Pascal Benkert

JAMA Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network.
Johannes Lorscheider, Alessio Signori, Suvitha Subramaniam, Pascal Benkert, Sandra Vukusic

J Neurol Neurosurg Psychiatry· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse Activity.
Mario Ocampo-Pineda, Alessandro Cagol, Pascal Benkert, Muhamed Barakovic, Po-Jui Lu

Neurol Neuroimmunol Neuroinflamm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.
Johanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, Aleksandra Maleska Maceski, Lester Melie-Garcia, Pascal Benkert

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis.
Etienne Mondesert, Constance Delaby, Elisa De La Cruz, Jens Kuhle, Pascal Benkert

Neurology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood Biomarkers.
Fabio Rossini, Tobias Moser, Michael Unterhofer, Michael Khalil, Rina Demjaha, Pascal Benkert

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Based Biomarkers for Identifying Disease Activity in AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Su-Hyun Kim, Ana Beatriz Ayroza Galvão Ribeiro Gomes, Patrick Schindler, Jae-Won Hyun, Ki Hoon Kim, Pascal Benkert

JAMA Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort.
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, Johannes Lorscheider, Riccardo Galbusera, Pascal Benkert

Mult Scler J Exp Transl Clin· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated Disease.
Ana Beatriz Ayroza Galvão Ribeiro Gomes, Su-Hyun Kim, Roxanne Pretzsch, Laila Kulsvehagen, Sabine Schaedelin, Pascal Benkert

Neurol Neuroimmunol Neuroinflamm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach.
Stefania Iaquinto, Benjamin Victor Ineichen, Anke Salmen, Jens Kuhle, Pascal Benkert

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis.
Gretel Sanabria-Diaz, Alessandro Cagol, Po-Jui Lu, Muhamed Barakovic, Mario Ocampo-Pineda, Pascal Benkert

Ann Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Pascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, Johanna Oechtering, Amar Zadic

Ann Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis